Skip to content
Dose Brief
Menu

Goldspan Health review

By Updated

Goldspan now describes clinical infrastructure through Altro Health, with compounded GLP-1 options but no complete current medication quote on its reviewed public pages.

Brief Score76/100Grade CNo. 80 in our directory
Visit Goldspan Health View the provider’s current plans and terms.
Semaglutide

Confirm current price

Earlier listing: from $229 per 28-day cycle. Current medication charge and supply period not confirmed.

Full price details

Compounded semaglutide offered. Current medication quote unknown; earlier observed from $229 per 28-day cycle for compounded semaglutide

Tirzepatide

Confirm current price

Earlier listing: from $299 per 28-day cycle. Current medication charge and supply period not confirmed.

Full price details

Compounded tirzepatide offered. Current medication quote unknown; earlier observed from $299 per 28-day cycle for compounded tirzepatide

Coverage
All 50 states advertised; the terms qualify access by therapy, state and medical history
Brand-name
Not confirmed

Prices checked against Goldspan Health's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— Earlier four-week prices remain historical. Current medication prices, supply periods and renewal terms require a new quote through the present Goldspan clinical service.

Goldspan Health in depth

A current quote is needed

Goldspan Health’s current weight-loss catalog lists compounded semaglutide and tirzepatide injections, with B12 or glycine options. The reviewed public pages do not establish current medication prices, covered supply periods or renewal charges. The earlier four-week prices above are historical observations and should not be used as current purchase quotes.

Before ordering, obtain the selected medication, formulation, prescribed quantity, amount due and later payment schedule together. A different ingredient blend is not evidence of better results or fewer side effects. The catalog’s role is to identify options for clinical discussion; it does not establish which prescription is appropriate or available for you.

Clinical infrastructure and prescription details

The website identifies Altro Health as its clinical infrastructure partner and describes prescriptions reviewed by clinicians before pharmacy fulfillment. Goldspan’s public clinical-routing links point toward that partner’s system. This is a change in the visible service presentation, not evidence that Goldspan has closed. The exact practice and clinician assigned to a patient still require confirmation.

The site describes fulfillment through licensed compounding pharmacies but does not identify the facility assigned to a particular prescription on these pages. Ask for its name, address and contact details. Broad references to 503A or 503B do not establish FDA approval of a compounded product. Our pharmacy verification guide explains the checks to make once a pharmacy is named.

The refund boundary starts with the order

The refund policy says sales are final once an order is placed, with a full refund when the clinician declines the requested therapy after reviewing the intake. That is an earlier purchase boundary than a policy that allows cancellation until shipping. Do not assume there is a general pre-shipment refund; request written clarification before checkout.

Lost or damaged shipments should be reported to support within the policy’s seven-day window for a replacement assessment. National availability is also qualified by therapy, state and medical history. Goldspan provides a clinical-partner disclosure and a clear non-approval exception, but the missing full quote and pharmacy assignment limit a confident comparison. Use our refund checklist before committing payment.

Sources we checked

Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

Goldspan Health scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability82/100
Transparency88/100
Access Breadth96/100
Clinical Oversight76/100
Track Record72/100

What we like

  • Identifies Altro Health as its clinical infrastructure partner
  • Lists semaglutide and tirzepatide formulations separately
  • Publishes a clinician-declined refund exception

The caveats

  • Current prices, supply periods and renewal charges require confirmation
  • The refund policy says sales are final once an order is placed
  • Named dispensing facility and therapy-specific state access remain unverified

The brief

Best for: Readers evaluating a clinician-led program who will obtain the current prescription price, pharmacy assignment and refund terms before ordering. Goldspan now describes clinical infrastructure through Altro Health, with compounded GLP-1 options but no complete current medication quote on its reviewed public pages.

Ranked #80 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Goldspan Health.

Closest here

The providers scoring nearest Goldspan Health — read each current assessment before choosing care.

Weighing Goldspan Health against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Goldspan Health, and every provider that outranks it is listed on the Goldspan Health alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Goldspan Health's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Goldspan Health's site. Not medical advice; see our disclosure.

← Back to all rankings